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Prostate cancer is the most frequently diagnosed solid organ cancer in men and is the second leading cause of cancer-related 
deaths in men in the United Kingdom. Commonly, it metastasizes to bones and lymph nodes, however, in advanced hormone-
refractory disease it may involve the skull base leading to associated cranial nerve palsies. Cranial nerve palsy as the presenting 
feature of advanced hormone-sensitive prostate cancer is extremely rare. To the best of our knowledge, we report the first case of 
solitary hypoglossal nerve palsy as the presenting feature of advanced prostate cancer. Neurologists, neurosurgeons and otolar-
yngologists may be the first clinicians to see such a patient; therefore, prostate cancer should be amongst the differential diagno-
ses considered in middle-aged and elderly men presenting with a cranial neuropathy and evidence of skull metastasis.  
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Prostate cancer commonly metastasizes to skeletal bones and 
lymph nodes. The vast majority of skeletal bone metastases in-
volve the axial spine, pelvis and femora [1]. Uncommonly, the 
skull base may be involved, almost exclusively; in prostate can-
cer this is associated with hormone-refractory cancer. Skull 
base involvement may lead to cranial neuropathies [2,3]. Cra-
nial neuropathy as the presenting feature is extremely rare [4], 
and although, there is one reported case of hypoglossal nerve 
involvement as the presenting feature, this was associated with 
involvement of multiple cranial nerves at the time of presenta-
tion. To the best of our knowledge, we report the first case of 
solitary hypoglossal nerve palsy as the presenting feature of ad-
vanced prostate cancer.   
CASE REPORT
A 74 year old male presented to his family physician with inter-
mittent right sided headaches of 2 months duration. There was 
no history of trauma, migraine and no associated neck pain. 
Otherwise, his general health was very good. Clinical examina-
tion was unremarkable, therefore, no further investigations were 
instigated and the patient was discharged with simple analgesia. 
  Four months later, he returned to his family physician with 
worsening symptoms, namely, the headaches became more in-
tense, persistent and were associated with slurred speech. Clini-
cal examination revealed atrophy of the right side of the tongue 
and deviation to the right on protrusion - right hypoglossal 
nerve palsy (Fig. 1) but no other neurological abnormalities 
were noted. He was referred to the local neurologist for further 
management. His baseline blood tests which included a whole 
blood count, urea and electrolytes, serum calcium and glucose 
were all normal. A computed tomography of the brain showed 
skull base sclerotic metastases, subsequently, a magnetic reso-
nance imaging of the brain revealed a focal abnormality of the 
right petrous bone with involvement of the hypoglossal nerve 
(Fig. 2). Bone metastases are commonly associated with thy-
roid, lung, breast, prostate and renal cancer, prostate cancer dif-
fers from the others by nature of its’ sclerotic bone metastases. 
Therefore, in addition to the chest X-ray, ultra sound scan of 
the renal tract, a serum prostate specific antigen (PSA) was re-
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quested, this was found to be elevated at 101 ng/mL. He was 
then referred to a urologist with suspected prostate cancer.
  He denied suffering from lower urinary tract symptoms and 
there was no history of back pain. Clinical examination of the 
prostate gland revealed a T3 cancer.  Subsequently, prostate gland 
biopsies confirmed a well-differentiated adenocarcinoma, Glea-
son score 3+3=6. A bone scan revealed widespread bony me-
tastases.
  Although, there has been no recovery of the hypoglossal 
nerve palsy following a bi-lateral scrotal orchidectomy, his re-
cent PSA level remains low at 3.2 ng/mL. At 32 months of fol-
low-up he has not required second line treatment or palliative 
radiotherapy.
DISCUSSION
Skull base metastatic cancer is often silent; however, as the dis-
ease advances it commonly results in cranial nerve palsies. A 
combination of computed tomography and magnetic resonance 
imaging of the head is used to diagnose skull base metastases. 
Although rare, cranial nerve palsies are associated with advanced 
prostate, breast, lymphoma and lung cancers [5]. Collet-Sicard 
syndrome is caused by a lesion that involves the lower 4 cranial 
nerves. It results in the paralysis of vocal cords, palate, trapezius 
and sternocleidomastoid muscles. Clinically, it results in anaes-
thesia of the larynx, pharynx and soft palate [6]. As described 
in our patient, unilateral occipital headache with ipsilateral hy-
poglossal nerve palsy is termed occipital-condyle syndrome [7]. 
Although, sclerotic bone metastases are commonly associated 
with prostate cancer, other cancers with bone metastases must 
be excluded; such as thyroid, lung, breast and renal cancer. Skull 
base involvement of metastatic prostate cancer is almost invari-
ably associated with known hormone-refractory disease. Cra-
nial neuropathy as the presenting feature is extremely rare [4], 
and although, there is one reported case of hypoglossal nerve 
involvement as the presenting feature, this was associated with 
involvement of multiple cranial nerves at the time of presenta-
tion. To the best of our knowledge, we report the first case of 
solitary hypoglossal nerve palsy as the presenting feature of ad-
vanced prostate cancer. Neurologists, neurosurgeons and oto-
laryngologists may be the first clinicians to see such a patient; 
therefore, prostate cancer should be amongst the differential di-
agnoses considered in middle-aged and elderly men presenting 
with a cranial neuropathy and evidence of skull metastasis. Fur-
thermore, if a PSA test is elevated then the patient should be re-
ferred to the urologist.  
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was re-
ported.
Fig. 1. Patient with a right sided hypoglossal nerve palsy.
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Fig. 2. Magnetic resonance imaging shows an abnormality of 
the right petrous bone and hypoglossal nerve.178    www.einj.or.kr
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